Kindred Biosciences

United States
Chester, Vermont, United States, 94010

Company profile

Kindred Biosciences company profile

Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.

Business identity

Contact email
[email protected]
Phone number
888-608-2542
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2012-01-01, Year

Headquarters

Postal code
94010
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
4
Total equity funding
$12.1M
Last funding
Post IPO Debt / $50M / 2019-10-02
Last equity funding
Post IPO Equity / $5.2M
Investors
2
Lead investors
1
Founders
2
Articles
66
Exited on
2013-12-12

Founders and investors

Founders

Denise BeversRichard Chin

Lead investors

SLR Capital Partners

Investors

General American Investors Company,IncSLR Capital Partners